Metaclipse Therapeutics is a clinical stage biotech company developing next-generation immunotherapies to treat cancer & vaccines to prevent infectious diseases using our proprietary biological adjuvants. Our personalized immunotherapy platform, Membrex™, has demonstrated promising preclinical data across multiple solid tumors with Phase 1 clinical trials for triple negative breast cancer (TNBC) and head and neck cancer (HNSCC) underway. We are committed to continuous innovation using biological adjuvants for therapeutic and preventative vaccines.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 3175 Presidential Dr, Atlanta,georgia,united States
- Phone
- (404)380-1342
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- metaclipsetherapeutics.com
- Keywords
- Triple Negative Breast Cancer, Personalized Cancer Immunotherapy, Head and Neck Cancer, Infectious Disease, Membrane-bound Adjuvant Technology.
- HQ
- Atlanta, Georgia
Metaclipse Therapeutics Corporation Questions
Metaclipse Therapeutics Corporation's helpline number is (404)380-1342
Metaclipse Therapeutics Corporation's website is metaclipsetherapeutics.com
Metaclipse Therapeutics Corporation's LinkedIn profile is https://www.linkedin.com/company/metaclipse-therapeutics
Metaclipse Therapeutics Corporation has
6 employees.
View email and phone details for 6
employees at Metaclipse Therapeutics Corporation.
Metaclipse Therapeutics Corporation's industry is
Biotechnology Research
Metaclipse Therapeutics Corporation's top competitors are
Geovax Labs, Inc.,
Phigenix, Inc.,
Aruna Bio, Inc.,
Lena Biosciences,
Moonlight Therapeutics,
Switch Therapeutics,
Antios Therapeutics,
Altesa Biosciences, Inc.,
Inhibikase Therapeutics, Inc.,
Piezo Therapeutics.
Metaclipse Therapeutics Corporation's categories are Biotechnology Research
Metaclipse Therapeutics Corporation's founding year is 2012
